Background: Pulmonary hypertension (PH) results in severely impaired quality of life (QoL) 
Introduction
Precapillary pulmonary hypertension (PH) is a condition, when mean pulmonary artery pressure increases significantly (≥ 25 mmHg) whereas the capillary wedge pressure remains within normal values (≤ 15 mmHg). It is represented in the clinical classification as group 1 -pulmonary arterial hypertension (PAH), group 3 -PH due to lung diseases and/or hypoxia, and group 4 -chronic thromboembolic PH (CTEPH). In Poland, the prevalence of PAH in adults is about 19.6 cases per million population. The number of patients increases year by year, suggesting that the disease is becoming better diagnosed [1] . A number of trials are in progress to improve life expectancy in this disease. However, the main problems that investigators face in planning such trials is a lack of ideal endpoints [2] .
Recent clinical studies have assessed Health Related Quality of Life (HRQL) using generic patient-reported outcome measures, such as the SF-36 [3] [4] [5] , EuroQol [6, 7] and Nottingham Health Profile [8] . HRQL provides information that is of interest to clinicians with a focus on symptoms and functional limitations resulting from a disease [9] . However, these measures demonstrate relatively low responsiveness, especially with PH patients [10] .
For example, to obtain a minimally important difference on the SF-36 domains, scores must improve between 13 and 25 points on a scale of 0-100. A modified version of the Minnesota Living with Heart Failure Questionnaire [11, 12] has also been used [13, 14] . However, the questionnaire was not designed for patients with PH and so it cannot be concluded that changes in score are valid.
Comprehensive disease-specific measures that directly address PH characteristics are required. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the first disease-specific questionnaire to assess both health-related QoL (symptoms and activity limitations) and QoL in patients diagnosed with PH [15] . CAMPHOR consists of three sections; symptoms (25 items), activities (15 items) and QoL (25 items). Quality of life is concerned with measuring how these symptoms and functioning affect the lives of patients, for example, whether they are able to fulfil their roles in life, communicate with others or interact socially. The measurement model, the needs-based model of QoL, argues that quality of life is the extent to which an individual is able to meet his or her basic human needs [16] .
CAMPHOR is widely used in international clinical studies for evaluating the benefits patients gain from alternative treatments for the condition. It is also used to monitor the progress as well as response to treatment of individual patients in clinical practice. It is an outcome measure that shows the effects of treatment from the viewpoint of the patient.
Research has shown that CAMPHOR scales are responsive to change, with effect sizes ranging from 0.31 to 0.69. It should be noted that CAMPHOR is at least as responsive as the 6-min walking test. This is often used as a primary endpoint in clinical trials, having demonstrated effect sizes that range from 0.16 to 0.34 [17] .
CAMPHOR was developed in the United Kingdom and has since been adapted into 18 additional languages [18] [19] [20] [21] [22] [23] [24] [25] . This report describes the adaptation of CAMPHOR into Polish and includes results from the translation, field-testing and psychometric evaluation of the new language version. A successful adaptation would provide a valid and reliable outcome measure for use in PH clinical practice and trials in Poland.
Methods
The process of adaptation of CAMPHOR questionnaire consisted of three main stages: translation (by means of a bilingual and lay panel), cognitive debriefing interviews with patients and a postal validation survey. Local ethics committee at Poznan University of Medical Sciences approved the study (resolution No. 728/16).
Stage 1: Translation process
The dual-panel methodology was used to translate CAMPHOR into Polish [26] 
Stage 2: Cognitive debriefing interviews
Cognitive debriefing interviews were conducted with PH patients from Warsaw. The patients were recruited through convenience sampling from a single center. Eleven of the interviewees had idiopathic pulmonary arterial hypertension (IPAH), one chronic thromboembolic pulmonary hypertension (CTEPH), one had PH associated with scleroderma and two had congenital heart disease. The aim of these interviews was to check the applicability, comprehension, relevance and comprehensiveness of the translated scales with appropriate patients. The semi-structured interviews were conducted face-to-face.
Respondents completed the questionnaire in the presence of an interviewer and were then asked to answer specific questions about the measure. [27] at the first administration.
Stage 3: Validation
Demographic (sex, age, marital status, occupation) and disease information (time since diagnosis, perceived general health and disease severity) was also collected.
Statistical analyses
Non-parametric statistical tests were used throughout the analyses due to the ordinal nature of the data. Internal consistency of CAMPHOR scales was evaluated by determining the Cronbach alpha coefficients. Test-retest reliability was examined using the Spearman rank correlation coefficients. Convergent validity was assessed by comparing scores on CAMPHOR scales with those on the NHP sections.
Known-group validity is the ability to distinguish between groups of patients who differ according to some known factor. The following variables were used for this purpose:
patient-perceived general health (very good/good/fair/poor) and patient-perceived disease severity (mild/moderate/quite severe/very severe). P-values < 0.05 were considered statistically significant.
Outcome measures

CAMPHOR. The CAMPHOR was originally developed and validated in the United
Kingdom [15] . It consists of a 25-item symptom scale (scored 0-25), a 15-item functioning scale (scored 0-30) and a 25-item QoL scale (scored 0-25). For all scales, a low score indicates better status. All validated language versions demonstrate good internal consistency, reproducibility and validity [18] [19] [20] [21] [22] [23] [24] [25] .
Nottingham Health Profile. The NHP is a 38-item questionnaire of perceived distress that has been widely used in health research [28] . It includes six sections, evaluating: energy level, pain, emotional reactions, sleep, social isolation and physical mobility. All sections are scored 0 to 100 with a lower score indicative of better health status.
Results
Translation
No significant difficulties were present during the translation process. In the adaptation process every additional step checks the correctness of previous stages and the results of the postal validation survey demonstrate whether the newly adapted version is reliable and valid. Therefore, no other investigations were required. Additionally, it is possible that certain words or concepts could not have been translated in a reasonable way however we did not find this to be the case. Where more than one translation was proposed by the bilingual panel, the lay panel generally reached agreement with little discussion. For example, the lay panel felt that the translation "Mam dosyć swojej choroby" expressed the feeling of being fed up more clearly than the alternative "Jestem zmęczony moją chorobą".
For the item 'I feel guilty asking for help', the bilingual panel suggested three translations ("Czuję się źle/zawstydzony/zażenowany, prosząc o pomoc"). The lay panel considered that "zawstydzony" could be misinterpreted as meaning shyness, while the word "zażenowany" was thought to be too complicated. Therefore, the panel agreed that "źle" was the most appropriate translation for this item.
Cognitive debriefing interviews
Fifteen cognitive debriefing interviews were conducted with patients. All patients understood clearly the purpose of the interview. Most of the patients responded well to the questionnaire, they thought it was simple and easy to complete. The items were clear and comprehensible. Interviewees felt that the items reflected their situation well, that they could relate to the ideas expressed and felt that no part of their experience of PH was missing. No changes were made to the questionnaire as a result of the cognitive debriefing interviews.
Validation
Fifty-seven participants were recruited at Time 1. Of these 56 (98.2%) patients completed and returned the questionnaire at Time 2. Table 2 shows descriptive statistics for the questionnaires at both time points. High floor effects (high number of patients scoring the minimum) were observed for most NHP sections. This indicates that the NHP is not well targeted to PH patients in this sample.
Internal consistency
For all CAMPHOR scales, the Cronbach alpha coefficients were above 0.8, indicating high internal consistency (Table 3) .
Test-retest reliability
Test-retest reliability for the three scales was 0.81 for Symptoms, 0.89 for Activities and 0.96 for QoL. These values suggest that the measure produces low levels of measurement error.
Convergent validity
Evidence of convergent validity can be seen in Table 4 where significant correlations between scores on CAMPHOR and NHP sections at Time 1 are shown. Table 5 shows CAMPHOR scores for patients grouped by gender and age (below vs.
Association with demographic factors
above median age). No significant differences in CAMPHOR scores were found between participants grouped by gender. The Mann-Whitney U test revealed there was a significant difference found between older and younger individuals for CAMPHOR Activities and QoL scales. Older patients had significantly worse scores on these two scales compared to younger patients. The χ 2 test of independence was performed to investigate age differences in greater detail. A significant association was found between age and perceived disease severity (χ² (1) = 4.9, p = 0.04). Similarly, a significant relation was found between age and perceived general health (χ² (1) = 7.8, p = 0.008).
Known group validity
Mann-Whitney U tests demonstrated statistically significant differences in CAMPHOR scores between patients who differed according to their perceived general health ( Fig. 1 ) and disease severity (Fig. 2) .
Patients who rated their disease severity as quite or very severe had significantly worse scores on all CAMPHOR scales than patients who rated their disease severity as mild or moderate. Respondents who considered their general health to be fair or poor had significantly worse CAMPHOR scores than patients who rated their health as good or very good. This demonstrates the ability of the Polish CAMPHOR to detect meaningful differences.
Discussion
This study shows that the Polish adaptation of CAMPHOR was successful. The new language version meets the expectations of good internal consistency, test-retest reliability, and convergent and known group validity. Similar findings have been reported for previous adaptations of the CAMPHOR [18] [19] [20] [21] [22] [23] [24] [25] .
Translations that are conceptually equivalent make it possible to compare scores across countries and to combine data from different countries in international clinical trials [14] . The dual panel methodology was applied. The translation methodology used in the adaptation of CAMPHOR has been shown to produce more acceptable translations and this method is preferred in the adaptation of all need-based measures [29] . Moreover, this method places great emphasis on achieving conceptual equivalence of translated items to the original.
It is important that translated items are expressed in everyday language, so that they are easily understood by future respondents, which is why the lay panel is used. In the next stage of adaptation, patients with PH in cognitive debriefing interviews confirmed the ease of answering particular items and no additional changes were necessary.. Furthermore, the use of a postal system at the validation stage was preferred, because the CAMPHOR is a patientreported questionnaire, so adding an interviewer might have introduced response bias.
In an evaluation of internal consistency, coefficients of all three CAMPHOR scales (Symptoms, Activities and QoL) were above 0.8, indicating high internal consistency.
Moreover, high test-retest coefficients obtained in all CAMPHOR scales confirmed its reproducibility. NHP was used in the validation of the original UK English CAMPHOR [15] and was adapted and validated in Polish for use as a comparator measure in the study of McKenna et al. [30] . The Polish NHP was developed using the same methodology as the Polish CAMPHOR. CAMPHOR consists of three separate sections measuring different types of outcomes: symptoms (impairment), activity limitations (disability) and QoL. The relations between scores on NHP Energy section and all three CAMPHOR scales reflect the nature of the disease. Physical mobility (disability) was highly related to CAMPHOR disability and also had an overall impact on QoL scores. Overall, QoL scores were most influenced by energy level, emotional reactions and physical mobility. These results were both expected and matched findings from previous CAMPHOR adaptations [21, [23] [24] [25] .
The Polish CAMPHOR scales were able to differentiate clearly between groups of patients depending on their perceived general health and perceived disease severity. The finding that older individuals reported significantly worse scores on the Activities and QoL scales was explored further. Investigation of the age differences revealed that older participants experience significantly worse in perceived disease severity and perceived general health compared to younger individuals. This is in line with previous research that found physical functioning worsened with age in PH patients [31] .
Quality of life (QoL) assessment can serve as an important endpoint especially in patients with an incurable disease. It differs from HRQL in that it assesses outcomes that are of relevance and interest to patients rather than physicians [9] . Carefully developed QoL scales provide a holistic picture of the impact of disease and its treatment on the patient. In the case of chronic or terminal illness where no effective cure is available, emphasis should be placed on improving QoL as the goal of treatment [9] .
The Polish CAMPHOR can be applied in both research and clinical settings in the Polish PH population. Previous research has shown that some endpoints do not indicate how patients respond to the illness [14] . This means that it is not possible to determine which interventions are of greatest value to them. Therefore, the wide range of issues covered by the CAMPHOR may support clinicians in the management and monitoring of patients.
Limitations of the study
A limitation of this study is the sample size. However, it was designed to establish the suitability of the Polish CAMPHOR rather than to describe in detail the impact of PH on patients.
Conclusions
The psychometric properties of the Polish version of CAMPHOR indicates that it is a valid and reliable measure of both HRQL and QoL in patients with PH. The new language version is recommended for use in the Polish population who speak Polish 
